Logo_arpbig_fondo_transparente_colores_blanco_letras_blanco
June 30, 2025
Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.
By fernando | |
Montero MM; Domene Ochoa S; López-Causapé C; Luque S; Sorlí…
Predictive Immunological, Virological, and Routine Laboratory Markers for Critical COVID-19 on Admission.
By fernando | |
García-Gasalla M; Ferrer JM; Fraile-Ribot PA; Ferre-Beltrán A; Rodríguez A;…
The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant.
By fernando | |
López MG; Chiner-Oms Á; García de Viedma D; Ruiz-Rodriguez P;…
Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPD.
By fernando | |
Shafiek H; Verdú J; Iglesias A; Ramon-Clar L; Toledo-Pons N;…
A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?
By fernando | |
Gómez-Zorrilla S; Becerra-Aparicio F; López Montesinos I; Ruiz de Gopegui…
Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber infection model.
By fernando | |
Montero MM; Domene-Ochoa S; López-Causapé C; Luque S; Sorlí L;…
Pseudomonas aeruginosa Susceptibility in Spain: Antimicrobial Activity and Resistance Suppression Evaluation by PK/PD Analysis.
By fernando | |
Valero A; Rodríguez-Gascón A; Isla A; Barrasa H; Del Barrio-Tofiño…
1 … 18 19 20